Literature DB >> 3501373

A human T lymphoblastic cell line lacks lamins A and C.

M N Guilly1, A Bensussan, J F Bourge, M Bornens, J C Courvalin.   

Abstract

Lamins A, B and C, the three major proteins of nuclear envelope, constitute a class of intermediate filament polypeptides. We have compared the amount of these polypeptides in two human cell lines, epithelial HeLa cells and T lymphoblasts KE 37. It was found that the three lamins were present in roughly equimolar stoichiometry in HeLa cells, while lamin B was the unique lamin component in T lymphoblasts. Moreover, 3-kb mRNA of lamin A and 2.1-kb mRNA of lamin C were detected with a human cDNA probe in HeLa cells but not in T lymphoblasts. These results suggest that (i) lamin B can build up the lamina structure in actively dividing somatic cells by itself, and (ii) lamin expression in lymphoid cells may be subject to important quantitative variations. Comparison of the lamin composition of human cloned T lymphocytes and Epstein-Barr virus-transformed human B lymphocytes confirmed this statement. The lamin B level was nearly equivalent in both cells but the content of lamins A and C varied to a large extent, being low in T cells and high in B cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501373      PMCID: PMC553851          DOI: 10.1002/j.1460-2075.1987.tb02715.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  ENZYME PATTERNS IN HUMAN TISSUES. I. METHODS FOR THE DETERMINATION OF GLYCOLYTIC ENZYMES.

Authors:  C E SHONK; G E BOXER
Journal:  Cancer Res       Date:  1964-05       Impact factor: 12.701

2.  Keratin-like proteins that coisolate with intermediate filaments of BHK-21 cells are nuclear lamins.

Authors:  A E Goldman; G Maul; P M Steinert; H Y Yang; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Interferon: a cytotoxic T lymphocyte differentiation signal.

Authors:  L K Chen; B Tourvieille; G F Burns; F H Bach; D Mathieu-Mahul; M Sasportes; A Bensussan
Journal:  Eur J Immunol       Date:  1986-07       Impact factor: 5.532

4.  Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins.

Authors:  F D McKeon; M W Kirschner; D Caput
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

5.  cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins.

Authors:  D Z Fisher; N Chaudhary; G Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  The nuclear lamin protein family in higher vertebrates. Identification of quantitatively minor lamin proteins by monoclonal antibodies.

Authors:  C F Lehner; V Kurer; H M Eppenberger; E A Nigg
Journal:  J Biol Chem       Date:  1986-10-05       Impact factor: 5.157

7.  The nuclear lamina is a meshwork of intermediate-type filaments.

Authors:  U Aebi; J Cohn; L Buhle; L Gerace
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

8.  A monoclonal antibody which recognises each of the nuclear lamin polypeptides in mammalian cells.

Authors:  B Burke; J Tooze; G Warren
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Alteration of vimentin intermediate filament expression during differentiation of human hemopoietic cells.

Authors:  K Dellagi; W Vainchenker; G Vinci; D Paulin; J C Brouet
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Vimentin gene: expression in human lymphocytes and in Burkitt's lymphoma cells.

Authors:  A Lilienbaum; V Legagneux; M M Portier; K Dellagi; D Paulin
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  21 in total

Review 1.  Inner nuclear membrane proteins: impact on human disease.

Authors:  Iván Méndez-López; Howard J Worman
Journal:  Chromosoma       Date:  2012-02-04       Impact factor: 4.316

Review 2.  Laminopathies and the long strange trip from basic cell biology to therapy.

Authors:  Howard J Worman; Loren G Fong; Antoine Muchir; Stephen G Young
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

3.  Characterization of a second highly conserved B-type lamin present in cells previously thought to contain only a single B-type lamin.

Authors:  T H Höger; K Zatloukal; I Waizenegger; G Krohne
Journal:  Chromosoma       Date:  1990-10       Impact factor: 4.316

4.  Direct actin binding to A- and B-type lamin tails and actin filament bundling by the lamin A tail.

Authors:  Dan N Simon; Michael S Zastrow; Katherine L Wilson
Journal:  Nucleus       Date:  2010-03-11       Impact factor: 4.197

5.  Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation.

Authors:  Sandrine Ruchaud; Nadia Korfali; Pascal Villa; Timothy J Kottke; Colin Dingwall; Scott H Kaufmann; William C Earnshaw
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

6.  Cell-extrinsic defective lymphocyte development in Lmna(-/-) mice.

Authors:  J Scott Hale; Richard L Frock; Sara A Mamman; Pamela J Fink; Brian K Kennedy
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

7.  Evaluation of mammalian cell-free systems of nuclear disassembly and assembly.

Authors:  Dominique C Vaillant; Micheline Paulin-Levasseur
Journal:  J Histochem Cytochem       Date:  2007-10-29       Impact factor: 2.479

Review 8.  "Laminopathies": a wide spectrum of human diseases.

Authors:  Howard J Worman; Gisèle Bonne
Journal:  Exp Cell Res       Date:  2007-03-30       Impact factor: 3.905

9.  Primary structure of a human arginine-rich nuclear protein that colocalizes with spliceosome components.

Authors:  N Chaudhary; C McMahon; G Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

10.  In vitro posttranslational modification of lamin B cloned from a human T-cell line.

Authors:  K M Pollard; E K Chan; B J Grant; K F Sullivan; E M Tan; C A Glass
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.